Skip to main content
PMC home page
American Journal of Human Genetics logoLink to American Journal of Human Genetics
. 1999 Jul;65(1):98–103. doi: 10.1086/302462

Noninvasive test for fragile X syndrome, using hair root analysis.

R Willemsen 1, B Anar 1, Y De Diego Otero 1, B B de Vries 1, Y Hilhorst-Hofstee 1, A Smits 1, E van Looveren 1, P J Willems 1, H Galjaard 1, B A Oostra 1
PMCID: PMC1378079  PMID: 10364521

Abstract

Identification of the FMR1 gene and the repeat-amplification mechanism causing fragile X syndrome led to development of reliable DNA-based diagnostic methods, including Southern blot hybridization and PCR. Both methods are performed on DNA isolated from peripheral blood cells and measure the repeat size in FMR1. Using an immunocytochemical technique on blood smears, we recently developed a novel test for identification of patients with fragile X syndrome. This method, also called "antibody test," uses monoclonal antibodies against the FMR1 gene product (FMRP) and is based on absence of FMRP in patients' cells. Here we describe a new diagnostic test to identify male patients with fragile X syndrome, on the basis of lack of FMRP in their hair roots. Expression of FMRP in hair roots was studied by use of an FMRP-specific antibody test, and the percentage of FMRP-expressing hair roots in controls and in male fragile X patients was determined. Control individuals showed clear expression of FMRP in nearly every hair root, whereas male fragile X patients lacked expression of FMRP in almost all their hair roots. Mentally retarded female patients with a full mutation showed FMRP expression in only some of their hair roots (<55%), and no overlap with normal female controls was observed. The advantages of this test are (1) plucking of hair follicles does no appreciable harm to the mentally retarded patient, (2) hairs can be sent in a simple envelope to a diagnostic center, and (3) the result of the test is available within 5 h of plucking. In addition, this test enabled us to identify two fragile X patients who did not show the full mutation by analysis of DNA isolated from blood cells.

Full Text

The Full Text of this article is available as a PDF (410.3 KB).

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Brown W. T., Houck G. E., Jr, Jeziorowska A., Levinson F. N., Ding X., Dobkin C., Zhong N., Henderson J., Brooks S. S., Jenkins E. C. Rapid fragile X carrier screening and prenatal diagnosis using a nonradioactive PCR test. JAMA. 1993 Oct 6;270(13):1569–1575. [PubMed] [Google Scholar]
  2. Dancis J., Silvers D. N., Balis M. E., Cox R. P., Schwartz M. S. Evidence for the derivation of individual hair roots from three progenitor cells. Hum Genet. 1981;58(4):414–416. doi: 10.1007/BF00282826. [DOI] [PubMed] [Google Scholar]
  3. Devys D., Lutz Y., Rouyer N., Bellocq J. P., Mandel J. L. The FMR-1 protein is cytoplasmic, most abundant in neurons and appears normal in carriers of a fragile X premutation. Nat Genet. 1993 Aug;4(4):335–340. doi: 10.1038/ng0893-335. [DOI] [PubMed] [Google Scholar]
  4. Fu Y. H., Kuhl D. P., Pizzuti A., Pieretti M., Sutcliffe J. S., Richards S., Verkerk A. J., Holden J. J., Fenwick R. G., Jr, Warren S. T. Variation of the CGG repeat at the fragile X site results in genetic instability: resolution of the Sherman paradox. Cell. 1991 Dec 20;67(6):1047–1058. doi: 10.1016/0092-8674(91)90283-5. [DOI] [PubMed] [Google Scholar]
  5. Gartler S. M., Gandini E., Angioni G., Argiolas N. Glucose-6 phosphate dehydrogenase mosaicism: utilization as a tracer in the study of the development of hair root cells. Ann Hum Genet. 1969 Oct;33(2):171–176. doi: 10.1111/j.1469-1809.1969.tb01642.x. [DOI] [PubMed] [Google Scholar]
  6. Gartler S. M., Scott R. C., Goldstein J. L., Campbell B. Lesch-Nyhan syndrome: rapid detection of heterozygotes by use of hair follicles. Science. 1971 May 7;172(3983):572–574. doi: 10.1126/science.172.3983.572. [DOI] [PubMed] [Google Scholar]
  7. Kooy R. F., Oostra B. A., Willems P. J. The fragile X syndrome and other fragile site disorders. Results Probl Cell Differ. 1998;21:1–46. doi: 10.1007/978-3-540-69680-3_1. [DOI] [PubMed] [Google Scholar]
  8. Nolin S. L., Glicksman A., Houck G. E., Jr, Brown W. T., Dobkin C. S. Mosaicism in fragile X affected males. Am J Med Genet. 1994 Jul 15;51(4):509–512. doi: 10.1002/ajmg.1320510444. [DOI] [PubMed] [Google Scholar]
  9. Oostra B. A., Jacky P. B., Brown W. T., Rousseau F. Guidelines for the diagnosis of fragile X syndrome. National Fragile X Foundation. J Med Genet. 1993 May;30(5):410–413. doi: 10.1136/jmg.30.5.410. [DOI] [PMC free article] [PubMed] [Google Scholar]
  10. Rousseau F., Heitz D., Biancalana V., Blumenfeld S., Kretz C., Boué J., Tommerup N., Van Der Hagen C., DeLozier-Blanchet C., Croquette M. F. Direct diagnosis by DNA analysis of the fragile X syndrome of mental retardation. N Engl J Med. 1991 Dec 12;325(24):1673–1681. doi: 10.1056/NEJM199112123252401. [DOI] [PubMed] [Google Scholar]
  11. Rousseau F., Heitz D., Oberlé I., Mandel J. L. Selection in blood cells from female carriers of the fragile X syndrome: inverse correlation between age and proportion of active X chromosomes carrying the full mutation. J Med Genet. 1991 Dec;28(12):830–836. doi: 10.1136/jmg.28.12.830. [DOI] [PMC free article] [PubMed] [Google Scholar]
  12. Sutcliffe J. S., Nelson D. L., Zhang F., Pieretti M., Caskey C. T., Saxe D., Warren S. T. DNA methylation represses FMR-1 transcription in fragile X syndrome. Hum Mol Genet. 1992 Sep;1(6):397–400. doi: 10.1093/hmg/1.6.397. [DOI] [PubMed] [Google Scholar]
  13. Turner G., Webb T., Wake S., Robinson H. Prevalence of fragile X syndrome. Am J Med Genet. 1996 Jul 12;64(1):196–197. doi: 10.1002/(SICI)1096-8628(19960712)64:1<196::AID-AJMG35>3.0.CO;2-G. [DOI] [PubMed] [Google Scholar]
  14. Verheij C., Bakker C. E., de Graaff E., Keulemans J., Willemsen R., Verkerk A. J., Galjaard H., Reuser A. J., Hoogeveen A. T., Oostra B. A. Characterization and localization of the FMR-1 gene product associated with fragile X syndrome. Nature. 1993 Jun 24;363(6431):722–724. doi: 10.1038/363722a0. [DOI] [PubMed] [Google Scholar]
  15. Verkerk A. J., Pieretti M., Sutcliffe J. S., Fu Y. H., Kuhl D. P., Pizzuti A., Reiner O., Richards S., Victoria M. F., Zhang F. P. Identification of a gene (FMR-1) containing a CGG repeat coincident with a breakpoint cluster region exhibiting length variation in fragile X syndrome. Cell. 1991 May 31;65(5):905–914. doi: 10.1016/0092-8674(91)90397-h. [DOI] [PubMed] [Google Scholar]
  16. Vermorken A. J., Weterings P. J., Spierenburg G. T., vanBennekom C. A., Wirtz P., deBruyn C. H., Oei T. L. Fabry's disease: biochemical and histochemical studies on hair roots for carrier detection. Br J Dermatol. 1978 Feb;98(2):191–196. doi: 10.1111/j.1365-2133.1978.tb01621.x. [DOI] [PubMed] [Google Scholar]
  17. Wildhagen M. F., van Os T. A., Polder J. J., ten Kate L. P., Habbema J. D. Explorative study of costs, effects and savings of screening for female fragile X premutation and full mutation carriers in the general population. Community Genet. 1998;1(1):36–47. doi: 10.1159/000016133. [DOI] [PubMed] [Google Scholar]
  18. Willemsen R., Mohkamsing S., de Vries B., Devys D., van den Ouweland A., Mandel J. L., Galjaard H., Oostra B. Rapid antibody test for fragile X syndrome. Lancet. 1995 May 6;345(8958):1147–1148. doi: 10.1016/s0140-6736(95)90979-6. [DOI] [PubMed] [Google Scholar]
  19. Willemsen R., Smits A., Mohkamsing S., van Beerendonk H., de Haan A., de Vries B., van den Ouweland A., Sistermans E., Galjaard H., Oostra B. A. Rapid antibody test for diagnosing fragile X syndrome: a validation of the technique. Hum Genet. 1997 Mar;99(3):308–311. doi: 10.1007/s004390050363. [DOI] [PubMed] [Google Scholar]
  20. Zavodny P. J., Petro M. E., Kumar C. C., Dailey S. H., Lonial H. K., Narula S. K., Leibowitz P. J. The nucleotide sequence of chicken smooth muscle myosin light chain two. Nucleic Acids Res. 1988 Feb 11;16(3):1214–1214. doi: 10.1093/nar/16.3.1214. [DOI] [PMC free article] [PubMed] [Google Scholar]
  21. de Graaff E., Willemsen R., Zhong N., de Die-Smulders C. E., Brown W. T., Freling G., Oostra B. Instability of the CGG repeat and expression of the FMR1 protein in a male fragile X patient with a lung tumor. Am J Hum Genet. 1995 Sep;57(3):609–618. [PMC free article] [PubMed] [Google Scholar]
  22. de Vries B. B., Wiegers A. M., Smits A. P., Mohkamsing S., Duivenvoorden H. J., Fryns J. P., Curfs L. M., Halley D. J., Oostra B. A., van den Ouweland A. M. Mental status of females with an FMR1 gene full mutation. Am J Hum Genet. 1996 May;58(5):1025–1032. [PMC free article] [PubMed] [Google Scholar]
  23. de Vries B. B., van den Ouweland A. M., Mohkamsing S., Duivenvoorden H. J., Mol E., Gelsema K., van Rijn M., Halley D. J., Sandkuijl L. A., Oostra B. A. Screening and diagnosis for the fragile X syndrome among the mentally retarded: an epidemiological and psychological survey. Collaborative Fragile X Study Group. Am J Hum Genet. 1997 Sep;61(3):660–667. doi: 10.1086/515496. [DOI] [PMC free article] [PubMed] [Google Scholar]

Articles from American Journal of Human Genetics are provided here courtesy of American Society of Human Genetics

RESOURCES